Pyridoxine-dependent seizures: Findings from recent studies pose new questions

Pediatric Neurology

Volumn 26, Issue 3, 2002, Pages 181-185

  Gospe Jr , Sidney M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIDOXINE;

AUTOSOMAL RECESSIVE DISORDER; DRUG DEPENDENCE; HUMAN; HYPOTHESIS; INTRACTABLE EPILEPSY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

HUMANS; METABOLISM, INBORN ERRORS; PYRIDOXINE; SEIZURES;

EID: 0036214478     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(01)00407-6     Document Type: Review

References (56)

1. Pyridoxine dependency; Report of a case of intractable convulsions in an infant controlled by pyridoxine
2. Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK
3. Pyridoxine dependency; An update
4. Current perspectives on pyridoxine-dependent seizures
5. Pyridoxine-dependent seizures, clinical and therapeutic aspects
6. Pyridoxine-dependent and pyridoxine-responsive seizures
7. Pyridoxine dependent seizures-a wider clinical spectrum
8. Atypical presentations of pyridoxine-dependent seizures; A treatable cause of intractable epilepsy in infants
9. Pyridoxine-dependent seizures requiring high doses of pyridoxine for control
10. 6-dependent epilepsy
11. Late-onset pyridoxine-dependent seizures; Report of two cases
12. Pyridoxine-dependent epilepsy; The need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion
13. Pyridoxine-dependent seizures responding to extremely low-dose pyridoxine
14. Glutamate decarboxylase is not genetically linked to pyridoxine-dependent seizures
15. A gene for pyridoxine-dependent epilepsy maps to chromosome 5q31
16. Mutation and polymorphic marker analyses of 65K- and 67K-glutamate decarboxylase genes in two families with pyridoxine-dependent epilepsy
17. Glutamate in pyridoxine-dependent epilepsy; Neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine
18. Reduced GABA synthesis in pyridoxine-dependent seizures
19. Low level of GABA in CSF in vitamin B6-dependent seizures
20. Disturbance of GABA metabolism in pyridoxine-dependent seizures
21. A subtype of pyridoxine-dependent epilepsy with normal CSF glutamate concentration
22. Pyridoxine-dependent seizures; Demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient
23. Global brain dysfunction in an infant with pyridoxine dependency; Evaluation with EEG, evoked potentials, MRI, and PET
24. Pyridoxine-dependent seizures; Report of a case with atypical clinical features and abnormal MRI scans
25. Pyridoxine-dependent seizures associated with white matter abnormalities
26. Longitudinal MRI findings in pyridoxine-dependent seizures
27. Pyridoxine-dependent epilepsy; EEG investigation and long-term follow-up
28. Pyridoxine dependent epilepsy; A suggestive electroclinical pattern
29. Familial intrauterine convulsions in pyridoxine dependency
30. Pyridoxine for neonatal seizures; An unexpected danger
31. Vitamin B6 and valproic acid in treatment of infantile spasms
32. Treatment of infantile spasms with high-dosage vitamin B6
33. Long-term follow-up of vitamin B6-responsive West syndrome
34. ACTH therapy for infantile spasms; A combination therapy with high-dose pyridoxal phosphate and low-dose ACTH
35. Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children
36. Effect of pyridoxine treatment in children with epilepsy
37. A 15-year follow-up of a boy with pyridoxine (vitamin B6)-dependent seizures with autism, breath holding, and severe mental retardation
38. Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy
39. Long-term follow-up of an individual with vitamin B6-dependent seizures
40. Neonatal seizures after pyridoxine use
41. Vitamin B6-dependency and infantile convulsions
42. Vitamin B6-dependent seizures; Pathology and chemical findings in brain
43. CSF glutamate/GABA concentrations in pyridoxine-dependent seizures; Etiology of pyridoxine-dependent seizures and the mechanisms of pyridoxine action in seizure control
44. Pyridoxine-responsive West syndrome and gamma-aminobutyric acid
45. Vitamin B6 safety issues
46. Anticonvulsant activity of muscimol and gamma-aminobutyric acid against pyridoxal phosphate-induced seizures
47. Proconvulsant effects induced by pyridoxine in young rats
48. A paradoxical rise of neonatal seizures after treatment with vitamin B6
49. A new method to detect point mutations in the gene for glutamic acid decarboxylase in patients with pyridoxine-dependent seizures
50. Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy
51. Influence of pipecolic acid on the release and uptake of [3H]-GABA from brain slices of mouse cerebral cortex
52. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome
53. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter
54. Molecular mechanisms of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell line
55. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates
56. Pyridoxal-5′-phosphate concentration as marker for vitamin-B6-dependent seizures in the newborn